90
Views
2
CrossRef citations to date
0
Altmetric
Original Research

The Efficacy and Toxicity of Neoadjuvant Chemotherapy Regimens of Epirubicin Plus Cyclophosphamide Followed by Docetaxel or Paclitaxel in Female Breast Cancer Patients

, , , , , , , , & ORCID Icon show all
Pages 1517-1527 | Published online: 15 Feb 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Marcela Tavares Luiz, Jessyca Aparecida Paes Dutra, Leonardo Delello Di Filippo, Alberto Gomes Tavares Junior, Larissa Bueno Tofani, Juliana Maldonado Marchetti & Marlus Chorilli. (2023) Epirubicin: Biological Properties, Analytical Methods, and Drug Delivery Nanosystems. Critical Reviews in Analytical Chemistry 53:5, pages 1080-1093.
Read now

Articles from other publishers (1)

Matthew G. Davey, Ray Abbas, Eoin P. Kerin, Maire Caitlin Casey, Andrew McGuire, Ronan M. Waldron, Helen M. Heneghan, John Newell, Ailbhe M. McDermott, Maccon M. Keane, Aoife J. Lowery, Nicola Miller & Michael J. Kerin. (2023) Circulating microRNAs can predict chemotherapy-induced toxicities in patients being treated for primary breast cancer. Breast Cancer Research and Treatment 202:1, pages 73-81.
Crossref